Investigation Overview
August 11, 2017 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of Skyline Medical Inc (NASDAQ:SKLN) was announced over potential breaches of fiduciary duties by certain officers and directors at Skyline Medical.
The investigation by a law firm concerns whether certain Skyline Medical directors breached their fiduciary duties and caused damage to the company and its shareholders.
Skyline Medical Inc. is a medical device company that develops and manufactures The STREAMWAY System, a solution for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care. Shares of Skyline Medical Inc (NASDAQ:SKLN) declined from $4.74 per share in November 2016 to as low as $1.31 per share in June 2017.